Antitumor Immunity Mediated by Engineered Stem Cells Exploiting TRAIL-Induced Cell Death and FLT3L Immunomodulation. van Schaik TA, Chen KS, Kanaya N, Moreno-Lama L, et al. Clin Cancer Res 2025;31:2793-2813.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

van Schaik TA, Chen KS, Kanaya N, Moreno-Lama L, et al. Antitumor Immunity Mediated by Engineered Stem Cells Exploiting TRAIL-Induced Cell Death and FLT3L Immunomodulation. Clin Cancer Res 2025;31:2793-2813.
PMID: 40238542